Form 4 for LLY Lilly (Eli)
Accepted 2024-02-02 00:00:00 ET · period of report 2024-02-01 · accession 0000059478-24-000017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-02 | 2024-02-01 | LLY | Norton Johna | EVP, Gbl Quality | M - OptEx | $0.00 | +1,268 | 31.4K | +4% | $0 |
| D | 2024-02-02 | 2024-02-01 | LLY | Norton Johna | EVP, Gbl Quality | F - Tax | $645.61 | -566 | 30.8K | -2% | -$365.4K |
| D | 2024-02-02 | 2024-02-01 | LLY | Norton Johna | EVP, Gbl Quality | M - OptEx | $0.00 | -1,268 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-01 | M | A | 1,268 | $0.00 | 31,382 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-01 | F | D | 566 | $645.61 | 30,816 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2024-02-01 | M | D | 1,268 | $0.00 | 0 | D | — · 2024-02-01 to 2024-02-01 | 1,268 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |